Michael Bommarito

Sector Strength in Materials, Weakness in Biotech

Hey Nick, I'm not sure whether we're using different "weeks" to do these numbers, but I've recently generated a summary of the last week for ETFs/CEFs that doesn't agree with your rankings. For instance, I know the other China funds performed in my top ten list (GXC,FXI), and HealthShares Emerging Cancer Fund and Europe HOLDRs (HHJ, EKH) got shaken badly. That aside though, my conclusions are pretty much the same, although you can see on my link above that European and Healthcare ETFs performed just about as poorly as Biotech.